[SCHEDULE 13G] Health Catalyst, Inc SEC Filing
Whetstone Capital Advisors, LLC and David Atterbury report beneficial ownership of 3,731,350 shares of Health Catalyst, Inc. common stock, representing 5.4% of the class. The filing shows the holders have shared voting and shared dispositive power over all 3,731,350 shares and no sole voting or dispositive power. The statement is submitted on a Schedule 13G related to the June 30, 2025 event and includes the filers' Kansas address and Health Catalyst's principal executive office in South Jordan, Utah. The filing includes a certification that the securities were not acquired to change or influence control of the issuer.
Whetstone Capital Advisors, LLC e David Atterbury dichiarano la titolarit脿 beneficiaria di 3.731.350 azioni ordinarie di Health Catalyst, Inc., pari al 5,4% della classe. La comunicazione indica che i soggetti detengono potere di voto e potere dispositivi condivisi su tutte le 3.731.350 azioni e che non hanno poteri di voto o dispositivi in via esclusiva. La dichiarazione 猫 presentata su uno Schedule 13G relativo all鈥檈vento del 30 giugno 2025 e riporta l鈥檌ndirizzo del depositante nel Kansas e la sede principale di Health Catalyst a South Jordan, Utah. Il documento include una certificazione che i titoli non sono stati acquisiti con l鈥檌ntento di modificare o influenzare il controllo dell鈥檈mittente.
Whetstone Capital Advisors, LLC y David Atterbury informan la propiedad beneficiaria de 3.731.350 acciones ordinarias de Health Catalyst, Inc., lo que representa el 5,4% de la clase. La presentaci贸n muestra que los titulares tienen poderes compartidos de voto y de disposici贸n sobre las 3.731.350 acciones y no poseen poderes de voto o de disposici贸n en exclusivo. La declaraci贸n se presenta en un Schedule 13G relacionado con el hecho del 30 de junio de 2025 e incluye la direcci贸n de los declarante en Kansas y la oficina principal de Health Catalyst en South Jordan, Utah. La presentaci贸n incorpora una certificaci贸n de que los valores no se adquirieron para cambiar o influir en el control del emisor.
Whetstone Capital Advisors, LLC鞕� David Atterbury電� Health Catalyst, Inc. 氤错喌欤� 3,731,350欤检棎 雽�頃� 鞁れ鞝� 靻岇湢甓岇潉 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 頃措嫻 韥措灅鞀れ潣 5.4%鞐� 頃措嫻頃滊嫟瓿� 氤搓碃頃╇媹雼�. 鞁犼碃靹滌棎 霐半ゴ氅� 氤挫湢鞛愲摛鞚� 3,731,350欤� 鞝勲秬鞐� 雽�頃� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓�鞚� 氤挫湢頃橁碃 鞛堨溂氅� 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潃 鞐嗢姷雼堧嫟. 鞚� 歆勳垹鞚� 2025雲� 6鞗� 30鞚� 靷贝瓿� 甏�霠悳 Schedule 13G鞐� 鞝滌稖霅橃棃鞙茧┌ 鞁犼碃鞚鸽摛鞚� 旌旍瀽鞀� 欤检唽鞕� Health Catalyst鞚� 氤胳偓鞚� 鞙犿儉欤� 靷毎鞀� 臁半崢 靻岇灛 靷鞁れ潉 韽暔頃╇媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 歃濌秾鞚� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲媹霛茧姅 鞚胳霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Whetstone Capital Advisors, LLC et David Atterbury d茅clarent la propri茅t茅 b茅n茅ficiaire de 3 731 350 actions ordinaires de Health Catalyst, Inc., repr茅sentant 5,4 % de la cat茅gorie. Le dossier indique que les titulaires exercent un pouvoir de vote partag茅 et un pouvoir de disposition partag茅 sur l鈥檈nsemble des 3 731 350 actions et n鈥檈xercent aucun pouvoir de vote ou de disposition exclusif. La d茅claration est soumise sur un Schedule 13G relatif 脿 l鈥櫭﹙茅nement du 30 juin 2025 et inclut l鈥檃dresse des d茅posants au Kansas ainsi que le si猫ge principal de Health Catalyst 脿 South Jordan, dans l鈥橴tah. Le d茅p么t comporte une certification attestant que les titres n鈥檕nt pas 茅t茅 acquis dans le but de modifier ou d鈥檌nfluencer le contr么le de l鈥櫭﹎etteur.
Whetstone Capital Advisors, LLC und David Atterbury melden wirtschaftliches Eigentum an 3.731.350 Stammaktien von Health Catalyst, Inc., was 5,4 % der Klasse entspricht. Die Einreichung zeigt, dass die Inhaber 眉ber alle 3.731.350 Aktien geteilte Stimmrechte und geteilte Verf眉gungsgewalt haben und keine alleinigen Stimm- oder Verf眉gungsrechte besitzen. Die Erkl盲rung wird in einem Schedule 13G im Zusammenhang mit dem Ereignis vom 30. Juni 2025 eingereicht und enth盲lt die Adresse der Melder in Kansas sowie das Hauptb眉ro von Health Catalyst in South Jordan, Utah. Die Einreichung enth盲lt ferner eine Best盲tigung, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen.
- Clear disclosure of the reporting persons' identity, address, and exact share count (3,731,350 shares).
- Stake size disclosed meets regulatory thresholds (5.4% of class), improving transparency for investors.
- Certification that the securities were not acquired to change or influence control, indicating passive intent.
- Shared voting power only (no sole voting power), which may limit clarity about who directs votes.
- No details on whether shares are held for clients or accounts beyond the reporting names, limiting context on economic ownership.
Insights
TL;DR: A passive 5.4% stake reported with shared voting/dispositive power, indicating notable but non-control ownership.
The Schedule 13G identifies Whetstone Capital Advisors, LLC and David Atterbury as reporting persons holding 3,731,350 shares (5.4% of the class) of Health Catalyst common stock. The position is reported with shared voting and dispositive power and zero sole power, consistent with collective ownership or advisory arrangement. The certification states the stake is not intended to influence control, aligning with Schedule 13G passive investor treatment. This is material in that it clears the 5% filing threshold and discloses the identity and authority structure of the holders.
TL;DR: Reporting clarifies voting/disposition rights and confirms passive intent, reducing immediate governance concern.
The form specifies shared voting and dispositive authority for all reported shares and includes a signed certification that the holdings are not for changing control. For governance assessment, the filing signals a meaningful minority stake without declared control intent. The disclosed addresses and signatures (dated 09/05/2025) provide verifiable contacts for shareholder communications. No group or subsidiary details are claimed, and items regarding ownership on behalf of others or group formation are marked not applicable.
Whetstone Capital Advisors, LLC e David Atterbury dichiarano la titolarit脿 beneficiaria di 3.731.350 azioni ordinarie di Health Catalyst, Inc., pari al 5,4% della classe. La comunicazione indica che i soggetti detengono potere di voto e potere dispositivi condivisi su tutte le 3.731.350 azioni e che non hanno poteri di voto o dispositivi in via esclusiva. La dichiarazione 猫 presentata su uno Schedule 13G relativo all鈥檈vento del 30 giugno 2025 e riporta l鈥檌ndirizzo del depositante nel Kansas e la sede principale di Health Catalyst a South Jordan, Utah. Il documento include una certificazione che i titoli non sono stati acquisiti con l鈥檌ntento di modificare o influenzare il controllo dell鈥檈mittente.
Whetstone Capital Advisors, LLC y David Atterbury informan la propiedad beneficiaria de 3.731.350 acciones ordinarias de Health Catalyst, Inc., lo que representa el 5,4% de la clase. La presentaci贸n muestra que los titulares tienen poderes compartidos de voto y de disposici贸n sobre las 3.731.350 acciones y no poseen poderes de voto o de disposici贸n en exclusivo. La declaraci贸n se presenta en un Schedule 13G relacionado con el hecho del 30 de junio de 2025 e incluye la direcci贸n de los declarante en Kansas y la oficina principal de Health Catalyst en South Jordan, Utah. La presentaci贸n incorpora una certificaci贸n de que los valores no se adquirieron para cambiar o influir en el control del emisor.
Whetstone Capital Advisors, LLC鞕� David Atterbury電� Health Catalyst, Inc. 氤错喌欤� 3,731,350欤检棎 雽�頃� 鞁れ鞝� 靻岇湢甓岇潉 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 頃措嫻 韥措灅鞀れ潣 5.4%鞐� 頃措嫻頃滊嫟瓿� 氤搓碃頃╇媹雼�. 鞁犼碃靹滌棎 霐半ゴ氅� 氤挫湢鞛愲摛鞚� 3,731,350欤� 鞝勲秬鞐� 雽�頃� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓�鞚� 氤挫湢頃橁碃 鞛堨溂氅� 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潃 鞐嗢姷雼堧嫟. 鞚� 歆勳垹鞚� 2025雲� 6鞗� 30鞚� 靷贝瓿� 甏�霠悳 Schedule 13G鞐� 鞝滌稖霅橃棃鞙茧┌ 鞁犼碃鞚鸽摛鞚� 旌旍瀽鞀� 欤检唽鞕� Health Catalyst鞚� 氤胳偓鞚� 鞙犿儉欤� 靷毎鞀� 臁半崢 靻岇灛 靷鞁れ潉 韽暔頃╇媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 歃濌秾鞚� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲媹霛茧姅 鞚胳霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Whetstone Capital Advisors, LLC et David Atterbury d茅clarent la propri茅t茅 b茅n茅ficiaire de 3 731 350 actions ordinaires de Health Catalyst, Inc., repr茅sentant 5,4 % de la cat茅gorie. Le dossier indique que les titulaires exercent un pouvoir de vote partag茅 et un pouvoir de disposition partag茅 sur l鈥檈nsemble des 3 731 350 actions et n鈥檈xercent aucun pouvoir de vote ou de disposition exclusif. La d茅claration est soumise sur un Schedule 13G relatif 脿 l鈥櫭﹙茅nement du 30 juin 2025 et inclut l鈥檃dresse des d茅posants au Kansas ainsi que le si猫ge principal de Health Catalyst 脿 South Jordan, dans l鈥橴tah. Le d茅p么t comporte une certification attestant que les titres n鈥檕nt pas 茅t茅 acquis dans le but de modifier ou d鈥檌nfluencer le contr么le de l鈥櫭﹎etteur.
Whetstone Capital Advisors, LLC und David Atterbury melden wirtschaftliches Eigentum an 3.731.350 Stammaktien von Health Catalyst, Inc., was 5,4 % der Klasse entspricht. Die Einreichung zeigt, dass die Inhaber 眉ber alle 3.731.350 Aktien geteilte Stimmrechte und geteilte Verf眉gungsgewalt haben und keine alleinigen Stimm- oder Verf眉gungsrechte besitzen. Die Erkl盲rung wird in einem Schedule 13G im Zusammenhang mit dem Ereignis vom 30. Juni 2025 eingereicht und enth盲lt die Adresse der Melder in Kansas sowie das Hauptb眉ro von Health Catalyst in South Jordan, Utah. Die Einreichung enth盲lt ferner eine Best盲tigung, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen.
FAQ
What stake in Health Catalyst (HCAT) is reported by Whetstone Capital Advisors?
Do the reporting persons have sole voting control over the HCAT shares?
Was this stake reported as intended to influence control of Health Catalyst?
Who signed the Schedule 13G for Whetstone Capital Advisors?
What are the reporting persons' addresses listed in the filing?
